Dimerix and Taiba enter into License Agreement for DMX-200
Filed with ASX · · 5 pages · English
In the deck
Story so far
Earlier from Dimerix
- Dimerix Receives PIP Approval from the UK MHRA
- Dimerix Completes $20M Placement
- Dimerix Successfully Passes Efficacy Interim Analysis
- PH3 Data Collection Complete for First Interim Analysis
- Half-Year Financial Report & Appendix 4D - 31 December 2023
Later from Dimerix
- Adolescent Recruitment into ACTION3 Clinical Trial
- Preliminary Final Report
- First patient enters into Open Label Extension study
- First Paediatric Site Activated and Trial Update
- ACTION3 Trial Recruitment and Multiregion Trial Site Update
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix